Log in
Enquire now
‌

US Patent 9511114 Neurotoxins exhibiting shortened biological activity

Patent 9511114 was granted and assigned to Merz Pharma on December, 2016 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors
Is a
Patent
Patent
0
Current Assignee
Merz Pharma
Merz Pharma
0
Date Filed
October 19, 2015
0
Date of Patent
December 6, 2016
0
Patent Applicant
Merz Pharma
Merz Pharma
0
Patent Application Number
14886485
0
Patent Citations Received
‌
US Patent 11707510 Nucleic acid-based botulinum neurotoxin for therapeutic use
0
Patent Inventor Names
Jurgen Frevert
0
Fred Hofmann
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
9511114
0
Patent Primary Examiner
‌
Padma V Baskar
0

Find more entities like US Patent 9511114 Neurotoxins exhibiting shortened biological activity

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.